Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Tafuri

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Current Urology|December 14, 2017
Simultaneous Measurements of Follicle Stimulating Hormone and Total Testosterone and Associations in Clinically Localized Prostate CancerAntonio B Porcaro, Salvatore Siracusano, Nicolò de Luyk, et al.
Medicina (Kaunas, Lithuania)|January 21, 2022
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?Guglielmo Mantica, Francesco Chierigo, Rafaela Malinaric, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 28, 2022
Impact of functional impairment and cognitive status on perioperative outcomes and costs after radical cystectomy: The role of Barthel IndexAlessandro Tafuri, Andrea Panunzio, Alessandra Gozzo, et al.
International Urology and Nephrology|July 6, 2021
Low endogenous testosterone levels are associated with the extend of lymphnodal invasion at radical prostatectomy and extended pelvic lymph node dissectionAntonio Benito Porcaro, Clara Cerrato, Alessandro Tafuri, et al.
Current Urology|October 12, 2019
Positive Association between Preoperative Total Testosterone and Lymph Node Invasion in Intermediate Risk Prostate CancerAntonio B Porcaro, Alessandro Tafuri, Marco Sebben, et al.
Tumori|May 2, 2018
Prostate-specific antigen associates with extensive lymph node invasion in high-risk prostate cancerAntonio B Porcaro, Paolo Corsi, Davide Inverardi, et al.
The Journal of Urology|September 9, 2020
High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States SeriesAndre Luis Abreu, Samuel Peretsman, Atsuko Iwata, et al.
Toxins|October 25, 2024
Response to Treatment with Botulinum Neurotoxin A (BoNT-A) in Children and Adolescents with Neurogenic Lower Urinary Tract Dysfunction and Idiopathic Overactive Bladder: A Systematic Review and Meta-AnalysisAndrea Panunzio, Rossella Orlando, Giovanni Mazzucato, et al.
Therapeutic Advances in Urology|August 28, 2019
Prostate volume index and prostatic chronic inflammation have an effect on tumor load at baseline random biopsies in patients with normal DRE and PSA values less than 10 ng/ml: results of 564 consecutive casesAntonio B Porcaro, Alessandro Tafuri, Marco Sebben, et al.
International Urology and Nephrology|October 5, 2022
Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mLAntonio Benito Porcaro, Alberto Bianchi, Giovanni Mazzucato, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Current Urology|December 14, 2017
Simultaneous Measurements of Follicle Stimulating Hormone and Total Testosterone and Associations in Clinically Localized Prostate CancerAntonio B Porcaro, Salvatore Siracusano, Nicolò de Luyk, et al.
Medicina (Kaunas, Lithuania)|January 21, 2022
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?Guglielmo Mantica, Francesco Chierigo, Rafaela Malinaric, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 28, 2022
Impact of functional impairment and cognitive status on perioperative outcomes and costs after radical cystectomy: The role of Barthel IndexAlessandro Tafuri, Andrea Panunzio, Alessandra Gozzo, et al.
International Urology and Nephrology|July 6, 2021
Low endogenous testosterone levels are associated with the extend of lymphnodal invasion at radical prostatectomy and extended pelvic lymph node dissectionAntonio Benito Porcaro, Clara Cerrato, Alessandro Tafuri, et al.
Current Urology|October 12, 2019
Positive Association between Preoperative Total Testosterone and Lymph Node Invasion in Intermediate Risk Prostate CancerAntonio B Porcaro, Alessandro Tafuri, Marco Sebben, et al.
Tumori|May 2, 2018
Prostate-specific antigen associates with extensive lymph node invasion in high-risk prostate cancerAntonio B Porcaro, Paolo Corsi, Davide Inverardi, et al.
The Journal of Urology|September 9, 2020
High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States SeriesAndre Luis Abreu, Samuel Peretsman, Atsuko Iwata, et al.
Toxins|October 25, 2024
Response to Treatment with Botulinum Neurotoxin A (BoNT-A) in Children and Adolescents with Neurogenic Lower Urinary Tract Dysfunction and Idiopathic Overactive Bladder: A Systematic Review and Meta-AnalysisAndrea Panunzio, Rossella Orlando, Giovanni Mazzucato, et al.
Therapeutic Advances in Urology|August 28, 2019
Prostate volume index and prostatic chronic inflammation have an effect on tumor load at baseline random biopsies in patients with normal DRE and PSA values less than 10 ng/ml: results of 564 consecutive casesAntonio B Porcaro, Alessandro Tafuri, Marco Sebben, et al.
International Urology and Nephrology|October 5, 2022
Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mLAntonio Benito Porcaro, Alberto Bianchi, Giovanni Mazzucato, et al.
Pageof 19